Myeloid cells as target of fingolimod action in multiple sclerosis

OBJECTIVE: To track the effects of fingolimod, an approved drug for multiple sclerosis (MS), on the activation of myeloid cells from the periphery to the CNS. METHODS: In vitro and ex vivo immunologic studies coupled with flow cytometry were performed to evaluate the action of fingolimod on lipopoly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurol Neuroimmunol Neuroinflamm
Main Authors: Di Dario, Marco, Colombo, Emanuela, Govi, Chiara, De Feo, Donatella, Messina, Maria José, Romeo, Marzia, Sangalli, Francesca, Moiola, Lucia, Rodegher, Mariaemma, Martino, Gianvito, Martinelli, Vittorio, Comi, Giancarlo, Farina, Cinthia
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635549/
https://ncbi.nlm.nih.gov/pubmed/26587553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000157
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados